Determinants of the haemoglobin level in patients with sickle cell disease living in sub‐Saharan Africa: Major impact of the country of residence and independent effects of leucocyte and platelet counts and haemolysis

Marica Rossi,Suzanne Belinga,Aissata Tolo,Saliou Diop,Ibrahima Diagne,David Chelo,Guillaume Wamba,Jean Paul Gonzalez,Cochise Abough'elie,Youssouf Traore,Indou Deme‐ly,Moussa Seck,Mor Diaw,Valerie Gbonon,Kouakou Boidy,Ismael Kamara,Robert Kitenge,Xavier Jouven,Léon Tshilolo,Dapa Diallo,Brigitte Ranque
DOI: https://doi.org/10.1111/bjh.19576
2024-06-05
British Journal of Haematology
Abstract:Multivariate analysis revealed independent associations between Hb level and several factors, including the country of residence, gender, BMI, haemolysis parameters (LDH level, reticulocyte count) and platelet and leucocyte counts. Summary The degree of anaemia in sickle cell disease (SCD) is a well‐known contributor to morbidity and mortality. We aimed to explore the factors affecting haemoglobin (Hb) level in African SCD patients, considering haemolysis biomarkers (LDH and bilirubin level, and reticulocyte count), leucocyte and platelet counts and socio‐demographic characteristics (gender, age group, country of residence and BMI). The research was part of the CADRE multinational cohort and involved 3699 SCD patients living in Mali, Senegal, Ivory Coast, Democratic Republic of Congo, Gabon and Cameroon: 2936 SS/Sβ0, 587 SC and 176 Sβ + patients with median Hb level of 8, 11.3 and 11.2 g/dL respectively (p
hematology
What problem does this paper attempt to address?